Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Takayasu Arteritis × CT-P13 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urogenital Neoplasms 2 Inflammatory Bowel Diseases 2 Crohn Disease 2 Colitis, Ulcerative 2 Colitis 2 Carcinoma, Non-Small-Cell Lung 2 Takayasu Arteritis 1 Melanoma 1 Lung Neoplasms 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Infliximab 1 CT-P13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02457585 2017-05-15

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Seoul National University Hospital

Phase 2 Unknown

Takayasu Arteritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡